Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, formerly known by OMP-131R10, constitutes a new monoclonal antibody developed to target granulocyte-macrophage colony-stimulating GM-CSF. Its mechanism of https://www.targetmol.com/compound/rosmantuzumab